# Maria Velinova – FDA 483, Jul 31, 2026

Source: https://www.keypedia.com/records/483/maria-velinova/1f1a0b24-74e5-461d-b1e8-27609bfb088e

> FDA 483 for Maria Velinova on July 31, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Maria Velinova
- Inspection Date: 2026-07-31
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Dr. Maria Velinova, a clinical investigator in Groubissen, The Netherlands, revealed a failure to conduct clinical studies in accordance with good clinical practices. The inspection found inadequate and inaccurate case histories, specifically regarding the documentation of sample processing parameters and investigational product administration for study subjects. These issues indicate significant deficiencies in record-keeping for clinical trials.

## Related Officers

- [Investigator](https://www.keypedia.com/people/lori-gioia/34b9339b-0bd2-4e41-8da1-b445ad829e53)

Company: https://www.keypedia.com/companies/maria-velinova/e7c70472-291a-4936-af96-1b8fa955c8fc

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8